Pacer Advisors
AGIO icon

Pacer Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Pacer Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
+928
New +$28.2K ﹤0.01% 2132
2024
Q3 		– Sell
-437
Closed -$18.8K – 2557
2024
Q2 		$18.8K Sell
437
-594
-58% -$21.4K ﹤0.01% 3440
2024
Q1 		$30.1K Buy
+1,031
New +$27.6K ﹤0.01% 3355
2021
Q2 		– Sell
-1,504
Closed -$78K – 1399
2021
Q1 		$78K Sell
1,504
-2,420
-62% -$120K ﹤0.01% 1325
2020
Q4 		$170K Buy
3,924
+1,695
+76% +$67K ﹤0.01% 1263
2020
Q3 		$78K Buy
+2,229
New +$97.7K ﹤0.01% 1279
2018
Q4 		– Sell
-3,328
Closed -$257K – 543
2018
Q3 		$257K Buy
+3,328
New +$268K 0.01% 977
2018
Q1 		– Sell
-1,075
Closed -$61K – 1040
2017
Q4 		$61K Buy
+1,075
New +$67.6K ﹤0.01% 994

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Pacer Advisors's AGIO Position: Q2 2026 in Review

Pacer Advisors opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 928 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #2132 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in AGIO as recently as Q2 2024.

Pacer Advisors first reported a position in AGIO in Q4 2017 and has held it in 8 quarters since. The position peaked at $257K in Q3 2018. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Pacer Advisors held 928 shares of Agios Pharmaceuticals worth $34K as of Q2 2026.
  • Agios Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2132 holding.
  • Pacer Advisors first reported a position in Agios Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
  • Pacer Advisors's Agios Pharmaceuticals position peaked at $257K in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.